已发表论文

miR-499a-5p 通过激活 Wnt/β-连环蛋白信号通路促进子宫平滑肌瘤细胞的增殖和迁移

 

Authors Ni J, Ma Y, Qiu J

Received 10 April 2025

Accepted for publication 15 July 2025

Published 21 July 2025 Volume 2025:17 Pages 2245—2253

DOI https://doi.org/10.2147/IJWH.S533729

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Vinay Kumar

Jingjing Ni, Yan Ma, Jianping Qiu

Department of Obstetrics and Gynecology, The Affiliated Suzhou Hospital of Nanjing Medical University (Suzhou Municipal Hospital), Suzhou, Jiangsu, 215000, People’s Republic of China

Correspondence: Jianping Qiu, Email 15722703657@163.com

Objective: This study aimed to investigate the functional role and underlying mechanism of miR-499a-5p in the progression of uterine leiomyoma (ULM).
Methods: Expression levels of miR-499a-5p were analyzed in ULM tissues and cells. Functional assays were conducted to evaluate the effects of miR-499a-5p knockdown or overexpression on cellular proliferation, migration, apoptosis, and cell cycle progression. The involvement of the Wnt/β-catenin signaling pathway was assessed using pathway-specific protein markers and lithium chloride (LiCl) as a chemical activator.
Results: miR-499a-5p was significantly upregulated in ULM tissues and cells. Its knockdown inhibited proliferation and migration, induced apoptosis, and caused cell cycle arrest at the G0/G1 phase. Additionally, downregulation of miR-499a-5p suppressed the activation of the Wnt/β-catenin pathway, an effect that was reversed by LiCl treatment.
Conclusion: miR-499a-5p facilitates the development of uterine leiomyoma by activating the Wnt/β-catenin signaling pathway. These findings suggest that miR-499a-5p may serve as a promising molecular biomarker and a potential therapeutic target for ULM management.

Keywords: miR-499a-5p, uterine leiomyoma, Wnt/β-catenin signaling pathway, proliferation, migration